cancer detection
The company offers an at-home test where a breath sample is collected and analyzed by trained dogs and AI to detect early-stage cancer.
The digital cytology system helps identify cervical cancer cells and precancerous lesions using deep learning AI and volumetric imaging technology.
The company will use the funds to enrich its technology, commercialize its MRD product and continue the development of its multi-cancer early detection offering.
The company said the AI integration has improved the biomarker detection of the Guardant cancer protein test by over 20%.
They have so far developed AI prediction models for breast, colon, and lung cancers.
The Galleri test checks for early signs of more than 50 types of cancer.
The company's technology looks to reduce the burden on pathologists reviewing digital slides, while also serving as a safety net to reduce errors.